Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "United States PENTHROX Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...
Mundipharma International Limited today announced that Penthrox ® (low dose methoxyflurane) has been granted marketing authorisation in France for the emergency relief of moderate to severe pain in ...
Penthrox, or the green whistle, is a fast onset, non-opioid analgesic. It is indicated for pain relief by self-administration in patients with trauma and those requiring analgesia for surgical ...
Patients will soon benefit from a unique invention, with emergency pain killer Penthrox receiving initial regulatory approval for sale in the European and UK markets. Australian healthcare company ...
Medical Developments International Limited (AU:MVP) has released an update. Medical Developments International Limited reported a revenue increase to $9.1 million for Q1 FY25, driven by higher pricing ...
Medical Developments International has had an investigative new drug application approved by Chinese authorities for its key Penthrox product, paving the way to clinical trials in China. Shares in the ...
Australian healthcare company Medical Developments International (MDI) and CSIRO have signed a technology deal to develop a new production process for the drug methoxyflurane – the pain-relieving ...
Bouygues Telecom , Orange and Free-iliad Group have signed a memorandum of understanding with Altice France to buy telecoms operator SFR for €20.35 billion ($23.44 billion), including debt, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results